Trial reportJournal of neurology2026
Magnetic resonance imaging vs computed tomography for baseline imaging evaluation in acute basilar artery occlusion.
Trial report in Journal of neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundThe optimal imaging modality, magnetic resonance imaging (MRI) or computed tomography (CT), for identifying good treatment candidates among patients with acute basilar-artery occlusion (BAO) remains unclear.
methodsThis was a post hoc analysis of the ATTENTION trial. Patients were categorized into MRI or CT groups according to the baseline imaging modality. The primary outcome was mRS 0-3 at 90 days. The secondary outcomes included mRS score shift on an ordinal scale, early neurological deterioration, time from stroke onset to arterial puncture, and time from onset to randomization. The safety outcome was mortality within 90 days. Clinical outcomes and workflow times were compared between the two groups.
resultsAmong 340 patients (CT: n = 277; MRI: n = 63), baseline imaging was not significantly associated with 90-day mRS 0-3 in the overall cohort (OR 0.99, 95% CI 0.50-1.95; P = 0.976). It remained highly consistent across both the endovascular treatment and best medical management subgroups. Baseline MRI assessment was not associated with significant workflow delays compared with CT, including time from stroke onset to randomization (mean difference [MD] 5.23 min; P = 0.843) and time to puncture (MD 13.16 min; P = 0.701). Furthermore, the association between imaging modality and outcomes was consistent across different time windows. DISCUSSION: In patients with acute BAO, we did not observe evidence supporting the preferential use of MRI over CT as the primary imaging strategy for patient selection. Conventional imaging appears sufficient as a first-line tool for selecting patients in clinical practice.
Indexed as
Identifiers
42893468What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.